Literature DB >> 8840835

Ibutilide and the treatment of atrial arrhythmias. A new drug--almost unheralded--is now available to US physicians.

D M Roden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8840835     DOI： 10.1161/01.cir.94.7.1499

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

Review 1.  What niche will newer class III antiarrhythmic drugs occupy?

Authors:  B N Singh; J S Sarma
Journal:  Curr Cardiol Rep       Date:  2001-07       Impact factor: 2.931

2.  Postoperative Cardiac Arrhythmias in Children.

Authors:  Seshadri Balaji
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-10

3.  Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group.

Authors:  M A Vos; S R Golitsyn; K Stangl; M Y Ruda; L V Van Wijk; J D Harry; K T Perry; P Touboul; G Steinbeck; H J Wellens
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

Review 4.  A benefit-risk assessment of class III antiarrhythmic agents.

Authors:  Bente Brendorp; Oledyg Pedersen; Christian Torp-Pedersen; Naji Sahebzadah; Lars Køber
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

5.  Management of late arrhythmias in adults with repaired congenital heart disease.

Authors:  Jennifer H Huang; Seshadri Balaji
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

Review 6.  LQT4 gene: the "missing" ankyrin.

Authors:  Sandro Yong; Xiaoli Tian; Qing Wang
Journal:  Mol Interv       Date:  2003-05

Review 7.  The use of drugs for cardioversion of recent onset atrial fibrillation and flutter. Focus on ibutilide.

Authors:  O A Obel; A J Camm
Journal:  Drugs Aging       Date:  1998-06       Impact factor: 3.923

Review 8.  Ischemic, genetic and pharmacological origins of cardiac arrhythmias: the contribution of the Quebec Heart Institute.

Authors:  Benoît Drolet; Chantale Simard; Laimonis Gailis; Pascal Daleau
Journal:  Can J Cardiol       Date:  2007-10       Impact factor: 5.223

9.  Ibutilide for the Cardioversion of Paroxysmal Atrial Fibrillation during Radiofrequency Ablation of Supraventricular Tachycardias.

Authors:  Kostas Polymeropoulos; Vassilios P Vassilikos; Lilian Mantziari; Stelios Paraskevaidis; Theodoros D Karamitsos; Sotirios Mochlas; Georgios Parcharidis; Georgios Louridas; Ioannis H Styliadis
Journal:  Cardiol Res Pract       Date:  2011-05-24       Impact factor: 1.866
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.